Promoted Content
Promoted Content

Market Place

Market Place

Menu

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Prices
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry

    Find Approved Neurology Drugs in Clinical Development in SOUTH AFRICA

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              Aspen Pharmacare Holdings

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              SOUTH AFRICA South Africa

              Contact Supplier Contact Supplier

              Virtual Booth Virtual Booth

              PMCA 2021

              Participation Not Confirmed

              Update your events

              Sandoz completes acquisition of Aspen’s Japanese operations, strengthening its position in world’s third largest market for generics and...

              Contact the Supplier

              Lead Product(s): Lidocaine Hydrochloride

              Therapeutic Area: Neurology Product Name: Undisclosed

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Sandoz B2B

              Deal Size: $440.0 million Upfront Cash: $330.0 million

              Deal Type: Acquisition January 31, 2020

              Details:

              The acquisition strengthens Sandoz’s presence in the hospital channel by complementing the broad Sandoz portfolio and pipeline of hospital generic and biosimilar products in Japan.

              PharmaCompass__DigitalAd